Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Single-Group Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms

NCT07078682 is registered in ClinicalTrials.gov with Zenchi, Inc. as lead sponsor.

NCT NCT07078682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07078682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Single-Group Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
Lead sponsor
Zenchi, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
August 1, 2025
Completion date
January 31, 2026
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leiomyoma, menstrual pain, uterine fibroids